Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:39:43.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added the Squamous cell carcinoma of the head and neck term and a Resources entry linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:31:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T18:02:31.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:00:39.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed. The earlier government funding/operating-status notice has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:57:21.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Site-wide notice added regarding a funding lapse that may affect data currency and operations, and the page revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:25:27.000Z thumbnail image

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.